Vietnam Receives H5N1 Human-Vaccine Production Technology (Vietnam)
This article was originally published in PharmAsia News
Executive Summary
The World Health Organization has donated $2.7 million worth of equipment and technology to the Nha Trang Vaccine Institute in Vietnam. The institute will use the technology to begin production of a vaccine to prevent the lethal H5N1 bird-flu strain. Installation is scheduled to be finished by the second quarter of 2008. Production is then set to begin by the early part of the fourth quarter. Not only will the institute be able to supply Vietnam, the vaccine is also expected to be approved for being exported. (Click here for more
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.